» Articles » PMID: 36004981

Fabrication and Characterization of Acute Myocardial Infarction Myoglobin Biomarker Based on Chromium-Doped Zinc Oxide Nanoparticles

Overview
Specialty Biotechnology
Date 2022 Aug 25
PMID 36004981
Authors
Affiliations
Soon will be listed here.
Abstract

In this article, we describe the fabrication and characterization of a sensor for acute myocardial infarction that detects myoglobin biomarkers using chromium (Cr)-doped zinc oxide (ZnO) nanoparticles (NPs). Pure and Cr-doped ZnO NPs (13 × 10, 20 × 10, and 32 × 10 atoms/cm in the solid phase) were synthesized by a facile low-temperature sol-gel method. Synthesized NPs were examined for structure and morphological analysis using various techniques to confirm the successful formation of ZnO NPs. Zeta potential was measured in LB media at a negative value and increased with doping. XPS spectra confirmed the presence of oxygen deficiency in the synthesized material. To fabricate the sensor, synthesized NPs were screen-printed over a pre-fabricated gold-coated working electrode for electrochemical detection of myoglobin (Mb). Cr-doped ZnO NPs doped with 13 × 10 Cr atomic/cm revealed the highest sensitivity of ~37.97 μA.cmnM and limit of detection (LOD) of 0.15 nM for Mb with a response time of ≤10 ms. The interference study was carried out with cytochrome c (Cyt-c) due to its resemblance with Mb and human serum albumin (HSA) abundance in the blood and displayed distinct oxidation potential and current values for Mb. Cr-doped ZnO NP-based Mb biosensors showed 3 times higher sensitivity as compared to pure ZnO NP-based sensors.

Citing Articles

Advances in textile-based microfluidics for biomolecule sensing.

Milic L, Zambry N, Ibrahim F, Petrovic B, Kojic S, Thiha A Biomicrofluidics. 2024; 18(5):051502.

PMID: 39296324 PMC: 11410389. DOI: 10.1063/5.0222244.


Advances in nanotechnological approaches for the detection of early markers associated with severe cardiac ailments.

Wang J, Zhang H, Wan W, Yang H, Zhao J Nanomedicine (Lond). 2024; 19(16):1487-1506.

PMID: 39121377 PMC: 11318751. DOI: 10.1080/17435889.2024.2364581.


Application of biomedical materials in the diagnosis and treatment of myocardial infarction.

Zhang J, Guo Y, Bai Y, Wei Y J Nanobiotechnology. 2023; 21(1):298.

PMID: 37626396 PMC: 10463704. DOI: 10.1186/s12951-023-02063-2.


A Paper-Based Photoelectrochemical Sensing Platform Based on In Situ Grown ZnO/ZnInS Heterojunctions onto Paper Fibers for Sensitively Detecting AFP.

Huang J, Li X, Xiu M, Huang K, Cui K, Zhang J Biosensors (Basel). 2022; 12(10).

PMID: 36290955 PMC: 9599276. DOI: 10.3390/bios12100818.

References
1.
Umar A, Akhtar M, Algadi H, Ibrahim A, Alhamami M, Baskoutas S . Highly Sensitive and Selective Eco-Toxic 4-Nitrophenol Chemical Sensor Based on Ag-Doped ZnO Nanoflowers Decorated with Nanosheets. Molecules. 2021; 26(15). PMC: 8347949. DOI: 10.3390/molecules26154619. View

2.
Radhakrishnan S, Sumathi C, Umar A, Kim S, Wilson J, Dharuman V . Polypyrrole-poly(3,4-ethylenedioxythiophene)-Ag (PPy-PEDOT-Ag) nanocomposite films for label-free electrochemical DNA sensing. Biosens Bioelectron. 2013; 47:133-40. DOI: 10.1016/j.bios.2013.02.049. View

3.
Osman B, Uzun L, Besirli N, Denizli A . Microcontact imprinted surface plasmon resonance sensor for myoglobin detection. Mater Sci Eng C Mater Biol Appl. 2013; 33(7):3609-14. DOI: 10.1016/j.msec.2013.04.041. View

4.
Guk K, Han G, Lim J, Jeong K, Kang T, Lim E . Evolution of Wearable Devices with Real-Time Disease Monitoring for Personalized Healthcare. Nanomaterials (Basel). 2019; 9(6). PMC: 6631918. DOI: 10.3390/nano9060813. View

5.
Tabish T, Hayat H, Abbas A, Narayan R . Graphene Quantum Dots-Based Electrochemical Biosensing Platform for Early Detection of Acute Myocardial Infarction. Biosensors (Basel). 2022; 12(2). PMC: 8869523. DOI: 10.3390/bios12020077. View